Factor xi/xia inhibitors

Intervention

1 paper2 findings

Outcomes

2

Thromboembolism

downin humans1

1 study
  1. Factor xi/xia inhibitors decrease thromboembolism in humans.

    “Some efficacy in preventing thromboembolic events has also been demonstrated, with ongoing trials further evaluating long-term safety and efficacy.”

    Reviewatrial fibrillation

    Use of factor XI/XIa inhibitors in patients with atrial fibrillation: Current progress and future prospects

    Ageing research reviews9 Sep 2025

More on Thromboembolism

Bleeding risk

downin humans1

1 study
  1. Factor xi/xia inhibitors decrease bleeding risk in humans.

    “Clinical trials have shown favorable safety profiles with reduced bleeding risks compared to traditional anticoagulants.”

    Reviewatrial fibrillation

    Use of factor XI/XIa inhibitors in patients with atrial fibrillation: Current progress and future prospects

    Ageing research reviews9 Sep 2025

Latest